Quarterly Consolidated Statement Of Cash Flows

Oncolys BioPharma Inc. - Filing #7723173

Concept As at
2018-06-30
2018-01-01 to
2018-06-30
As at
2017-12-31
2017-01-01 to
2017-06-30
As at
2017-06-30
As at
2016-12-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-611,836,000 JPY
-515,048,000 JPY
Interest and dividends received
142,000 JPY
427,000 JPY
Interest paid
-1,502,000 JPY
-1,653,000 JPY
Income taxes paid
-3,703,000 JPY
-3,186,000 JPY
Net cash provided by (used in) operating activities
-616,900,000 JPY
-519,460,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,129,000 JPY
-965,000 JPY
Purchase of investment securities
-356,310,000 JPY
-55,670,000 JPY
Net cash provided by (used in) investing activities
242,560,000 JPY
343,218,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
100,000,000 JPY
Repayments of long-term borrowings
-16,668,000 JPY
-11,536,000 JPY
Proceeds from issuance of shares
JPY
955,637,000 JPY
Net cash provided by (used in) financing activities
-32,071,000 JPY
1,042,018,000 JPY
Effect of exchange rate change on cash and cash equivalents
-8,938,000 JPY
-7,478,000 JPY
Net increase (decrease) in cash and cash equivalents
-415,350,000 JPY
858,298,000 JPY
Cash and cash equivalents
1,507,104,000 JPY
1,922,454,000 JPY
2,277,291,000 JPY
1,418,993,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.